The structural profiles are close, with Ionis Pharmaceuticals carrying a narrow edge on growth. The remaining gap is narrow enough that the comparison remains open to different readings. In the market, Snowflake carries the stronger setup — intact trend against Ionis Pharmaceuticals's broken trend. That leaves a split case: the structural lead stays with Ionis Pharmaceuticals, but the market is not currently confirming it.
The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the Russell 1000 universe, making them directly comparable.
The comparison stays tight enough that no single part of the profile fully breaks it open.
This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.
The pair shares a valid long-term profile match, but the trajectories are not especially close.
The strongest overlap appears in investment intensity and recent revenue growth.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
Score differences across key dimensions.
Left means cheaper relative valuation. Higher means stronger structure.
The setup is mixed: neither company clearly combines the stronger profile with the more supportive price setup.
Valuation position uses peer-relative valuation score and Forward P/E where available.
Where IONS and SNOW each sit in their own 5-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
Growth adds another layer to the lead, with a very wide gap in revenue growth between the two companies.
On the market side, Snowflake carries the stronger trend while Ionis Pharmaceuticals's trend has broken — the market setup does not confirm the structural advantage.
The lead is visible, but it is still concentrated in one main area.
Break down the IONS vs SNOW comparison across all dimensions with the full interactive tool.
Explore how IONS and SNOW each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.